Enocitabine, CAS 55726-47-1

Formulation: A solid

Formal Name: N-(1-β-D-arabinofuranosyl-1,2-dihydro-2-oxo-4-pyrimidinyl)-docosanamide

Purity: ≥95%

Formula Markup: C31H55N3O6

Formula Weight: 565,8

Shelf life (days): 1460

CAS Number: 55726-47-1

Notes: Enocitabine is a lipophilic prodrug form of the nucleoside analog cytarabine (Item No. 16069) that contains a docosanoic acid (Item No. 9000338) moiety.{61926} It is resistant to deamination by cytidine deaminase.{61927} Enocitabine reduces the virus yield in the supernatant of CMV-infected Vero cells (EC90 = 0.5 µg/ml) and inhibits viral DNA synthesis when used at a concentration of 5 µg/ml.{61928} It increases survival in an L1210 murine skin lymphocytic leukemia model in a dose-dependent manner.{61927} Formulations containing enocitabine have been used in the treatment of acute myeloid leukemia (AML).

• Artikelnummer: CAY36538-10
• Hersteller: Cayman Chemical
• Hersteller Artikelnummer: 36538-10
• Green Labware: Nein
• Verpackungseinheit: 10 mg
• Mengeneinheit: STK
• Methode: Reinstoffe